The Effect of Double Injection Erector Spinae Plane Block on Postoperative Pain Following Breast Surgery

Breast Cancer Clinical Trial

Official title:

The Effect of Double Injection Erector Spinae Plane Block on Postoperative Pain Following Breast Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03415646
• Other study ID #: 2017-377
• Status: Completed
• Phase: N/A
• First received: January 10, 2018
• Last updated: March 7, 2018
• Start date: February 3, 2018
• Est. completion date: March 7, 2018

Study information

• Verified date: March 2018
• Source: Kocaeli University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Postoperative analgesia in breast surgery is a difficult and overworked issue due to extensive surgery and complex innervation of the breast. Erector spinae plane block (ESB) is a new defined regional anesthesia technique for thoracic analgesia.Main purpose of this study was to evaluate the analgesic effect of ultrasound guided double injection ESB in breast surgery.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: March 7, 2018
• Est. primary completion date: March 5, 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 25 Years to 70 Years

Eligibility

Inclusion Criteria:

• 25-70 years of age

• ASA I-II

• Undergoing elective breast cancer surgery

Exclusion Criteria:

• obesity (body mass index >35 kg/m2)

• infection of the skin at the site of needle puncture area

• patients with known allergies to any of the study drugs

• coagulopathy

• recent use of analgesic drugs.

Related Conditions & MeSH terms

• Breast Cancer
• Pain, Postoperative
• Postoperative Pain

Intervention

Other:
• Erector Spinae Plane Block
erector spinae plane block with double level injection will be administered before the surgery

Device:
• Intravenous Morphine patient controlled analgesia device
24 hour morphine consumption will be recorded

Locations

Country	Name	City	State
Turkey	Kocaeli University Hospital	Izmit	Kocaeli

Sponsors (1)

Lead Sponsor	Collaborator
Kocaeli University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Morphine consumption		24 hour postoperatively